NewsPronto

 
Times Advertising


.

ACN Newswire

Read more press releases from ACN Newswire here

Eisai: Approval of Antiepileptic Drug Fycompa in Japan for Monotherapy and Pediatric Indications for Partial-Onset Seizures, as well as a New Formulation

  • Written by ACN Newswire

image

TOKYO, Jan 23, 2020 - (JCN Newswire) - Eisai Co., Ltd. has obtained the approvals of supplementary new drug applications in Japan for its in-house developed antiepileptic drug (AED) Fycompa (perampanel) for an additional indication for monotherapy of partial-onset seizures and an additional indication for partial-onset seizures in pediatric...

Read more: Eisai: Approval of Antiepileptic Drug Fycompa in Japan for Monotherapy and Pediatric Indications...